Regulatory & Legal

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

An exclusive FDA invite positions IKE Tech’s blockchain-based age-gating system at the heart of future vape regulation, a move that could redefine the industry.

Nasdaq-listed Zeta Network Group is exploring real-world asset tokenization, signaling a pivotal move beyond Bitcoin for institutional treasury management.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

For the second straight year, Collette Health is #1 in virtual care. Discover how its integrated platform is redefining hospital efficiency and patient safety.

After uniting nine acquired firms under one brand, NowVertical is shifting its focus to organic growth, leveraging integrated operations to exceed targets.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

Thousands, including minors, were secretly filmed in Northwell Health bathrooms. A new lawsuit exposes the breach and a year-long notification delay.

Six months in, SK Telecom's Haein GPU cluster is more than a service; it's the national infrastructure engine driving South Korea's AI sovereignty.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

New 4-year real-world data shows Zevra's drug stabilizes the rare, fatal 'Childhood Alzheimer's' disease, marking a milestone for patients and families.

With a key cancer drug awaiting FDA review and pivotal data imminent, Celcuity faces investors at a critical juncture. What will they be looking for?

A new six-month injection for Central Precocious Puberty shows strong safety and efficacy, promising to ease the treatment burden for children and families.

After a 20-year partnership, investment firm Wendel sells specialty coatings leader Stahl to Henkel, signaling a major industry consolidation.

WM Technology adds tech and finance veterans to its board and solidifies its CFO role, signaling a strategic pivot for growth and stability in a complex market.

As Par Pacific sets to release its Q4 2025 results, investors are watching for updates on its new renewables venture and sustained financial performance.

Ottawa prepares to unveil a sweeping plan for a digitally connected health system, promising better care but facing major hurdles in privacy and security.

Creator commerce firm Amaze Holdings cancels a special meeting on a crucial stock dilution vote, raising questions about shareholder support and strategy.

IDrive CEO Raghu Kulkarni proposes a new model of reality, deriving quantum mechanics from a 'pixelated' vacuum. Can it solve physics' biggest mysteries?

A new bipartisan law injects vital funds into neuromuscular disease research, a victory driven by years of relentless patient advocacy. Here's what it means.